News

Mr Duggan served as chairman of the board of directors of Computer Motion, a computerized surgical systems company, from 1990 to 2003 and CEO from 1997. Computer Motion

The first tranche of $8.4 million has been completed, led by Novo Ventures and Novartis Ventures with participation from the Roche Venture Fund. Jack Nielsen of Novo Ventures

The open-label, dose-escalation study of elesclomol in up to 30 subjects with advanced metastatic or unresectable solid tumors is designed to identify the maximum tolerated dose of elesclomol

Prior to joining MedMira, Smith was a member of the Nova Scotia Legislature for 19 years, serving in various roles including Minister of Health. Born and raised in

The transaction is expected to generate cash proceeds of $275 million from the sale of property and equipment. From these proceeds, $30 million will be deferred and placed

The studies, funded by the National Institutes for Health’s CounterACT program, have been designed to test the efficacy of AEOL 10150 as a treatment for damage to the

This change follows the resignation of Richard Donnelly from his roles as an officer and director of AspenBio. Mr Donnelly has indicated that he plans to pursue other

Through this agreement, BioWisdom gains access to the data within Asterand’s proprietary Target Evaluator database. The database consists of quantitative human gene expression profiles that chart the expression

Curis, a drug development company, has announced that its collaborator Genentech and the National Cancer Institute’s division of cancer treatment and diagnosis are planning to enter into a